 1. Patients must have previously treated relapsed andor refractory MCL, follicular lymphoma grade 1-3, marginal zone lymphoma, or non-germinal center B-cell diffuse large B-cell lymphoma with 1 - 4 prior lines of therapy. prior anthracycline, rituximab or stem cell transplant auto or allo are acceptable. 